NAD Nasal Spray Dosage: Why Your Prescriber Sets It

The Real Peptides NAD+ research spray is labelled 1000mg, and that number describes the total listed content of a $120.00 bottle, not an amount for anyone to take. That distinction sits at the center of every NAD nasal spray dosage question. There is no FDA-approved human dose for an NAD+ nasal spray, and for the one prescription spray on this site, Arc-1's $149.99 product, the prescribing physician sets it.

We never provide dosing information, product schedule or instructions for usage with NAD+ product. This page clarifies reasons for this position, as opposed to a manipulation.

No Approved Human Dose Exists

None of the NAD+ nasal spray products is approved by the FDA as a medication, which means there is no dose for human use to refer to. Approved medications have official dosing indication, derived from adequate clinical trials, but NAD+ nasal sprays have not been subject to that.

Research-grade sprays, such as the one from Real Peptides, are intended for research use only and are marked as not suitable for human consumption. Such a product is devoid of any dose for humans by definition. Compounded prescription sprays are created specifically for a patient according to a prescription, and this dosage forms part of that prescription, making it a private number.

Therefore, when searching for the appropriate dosage of NAD nasal spray, it’s essential to question how that number was generated as the one you may have found is likely not based on an approved labeling.

Why Animal and Cell Research Cannot Set One

Most strong NAD+ data come from cell and animal models, and doses used in that work cannot be translated to people. Animal research uses amounts chosen for the model, delivered by routes that often differ from a nasal spray.

Even the human evidence for injectable NAD+ is limited, and the nasal route has limited bioavailability data on top of that. Without knowing how much crosses the nasal lining, nobody can work backward from a lab result to a spray amount. Our page on how NAD nasal spray is supposed to work goes through that chain step by step.

Forum Protocols Are Anecdotes

The "protocols" you will find on social networks or forums are individual anonymized accounts and therefore do not serve as proof. They cannot assist you in determining if an amount is safe, does anything, etc., or comparing one product from one company with another product from another vendor.

We see the same problems in them again and again:

• No way to verify what was actually in the bottle, which matters when liquid products can leak or arrive under-filled.
• No control group, so any effect could be expectation or coincidence.
• Numbers copied between posts until they look like a standard, when they never were.
• Research-only products described as if they were supplements.

A protocol repeated a thousand times is still an anecdote. If you want to know what is documented about reactions, the side effects page covers it.

What FDA Has Signaled About Dosing Guidance

FDA considers dosing instructions listed on the website of a research supplier as an indication that it is a product intended for human application. This fact became evident from the warning letters sent on August 24th, 2026 by the FDA to five online peptide suppliers.

The FDA stated that the labels of "only for research purposes" did not resolve the matter and that the entire site is evaluated. Furthermore, the disease claims, dosing recommendations, reconstitution measures, and bacteriostatic water available next to injectables were mentioned. Despite the fact that NAD+ was not among the mentioned products, a research seller providing information about NAD+ quantities near its spray is under the same scrutiny of the FDA. To me, when a supplier provides the dosage information of a research product, it makes me buy elsewhere rather than making my life easier.

For the Prescription Spray, the Prescriber Decides

With a prescription spray provided by a telemedicine provider such as Arc-1, the telemedicine provider decides how much of it and how frequently it has to be administered. That is what makes prescription medication more effective than research medication.

Arc-1 runs on an online medical intake and a physician consultation, and the pharmacy compounds the spray to the prescription. The listing does not state a strength, which is consistent with the amount being set per patient. If you have questions about the amount, ask the prescriber, and raise any other medicines or conditions during the intake. The prescription page walks through the process.

Reading a Label Without Reading It as a Dose

listing the specifications of NAD+, it is important to understand that the figures are not instructions on how to use the product. One of the most common errors in interpretation is taking the figures to be the dosage for a NAD nasal spray.

None of these figures tells you what a person should use. If you are considering NAD+ for yourself, talk to your doctor, and if you go the telehealth route, let the prescriber set it. Price comparisons for all three are on the cost page.